Neoadjuvant nivolumab plus chemotherapy: Examining the clinical trial that led to FDA approval
Immunotherapy is transforming cancer treatment. One such immunotherapy drug called, nivolumab has been approved by FDA for lung cancer.
top of page
bottom of page